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Abstract
Background: Injecting drugs is the major driving force of human immunodeficiency virus (HIV) epidemic in
Northeastern India. We have assessed the spatial distribution of locations where injecting drug users (IDU)
congregate, as well as the risk behaviour and key characteristics of IDUs to develop new strategies strengthening
intervention measures for HIV prevention in this region.
Methods: Locations of IDUs congregation for buying and injecting drugs were identified through Key Informants
(KI). Verification of the location and its characteristics were confirmed through field visits. We also conducted semi-
structured and structured interviews with IDUs to learn more about their injecting behaviour and other
characteristics.
Results: Altogether, 2462 IDU locations were identified in 5 states. The number of IDU locations was found to be
greater in the states bordering Myanmar. Private houses, parks, abandoned buildings, pharmacies, graveyards, and
isolated places were the most frequently chosen place for injecting drugs. Many injecting locations were visited by
IDUs of varying ages, of which about 10-20% of locations were for females. In some locations, female IDUs were
also involved in sex work. Sharing of needle and syringes was reported in all the states by large proportion of
IDUs, mainly with close friends. However, even sharing with strangers was not uncommon. Needle and syringes
were mainly procured from pharmacies, drug peddlers and friends. Lack of access to free sterile needles and
syringes, and inconsistent supplies from intervention programs, were often given as the cause of sharing or re-use
of needles and syringes by IDUs. Most of the IDUs described a negative attitude of the community towards them.
Conclusion: We highlight the injection of drugs as a problem in 5 Northeastern India states where this is the
major driving force of an HIV epidemic. Also highlighted are the large numbers of females that are unrecognized
as IDUs and the association between drug use and sex work. Understanding of risk behaviours and other key
charecteristics of IDUs in the region will help in strengthening harm reduction efforts that can prevent HIV
transmission.
Background
Abuse in injecting drugs and its association with human
immunodeficiency virus (HIV) infection has become an
important public health concern during last two decades
in many countries worldwide. Some serious blood borne
viral infections, e.g. hepatitis B (HBV) and hepatitis C
(HCV) viruses adds to the misery. In India, illicit injec-
tion of drugs is already recognized as a major public
health problem in Northeastern states. Heroin injection
among IDU became popular in 1980s among the youths
of the Northeast, particularly in Manipur [1]. The proxi-
mity of the Northeast to the Golden Triangle, the
world’s major point of illicit drug production, has tradi-
tionally been viewed as the most important reason for
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seroprevalence of HIV among IDUs reached 50% by
1990 in Manipur [2,3]. Within a short span, 2 other
northeastern states of India bordering Myanmar (Naga-
land and Mizoram) also experienced a similar epidemic.
The estimated prevalence of HIV among IDUs was 13%
in Nagaland in 1998, and reached almost 10% in
Mizoram by 2000 [4]. Prevalence also exceeded the 5%
level in Assam in 2002 [5]. Subsequently, the epidemic
spread to the wider populations from injecting drug
users (IDU) through their sexual partners [6,7]. Manipur
and Nagaland are 2 of the 6 HIV high prevalence states
of India, where HIV among antenatal mothers is >1%
[5]. Different strategies have been adopted to prevent
HIV transmission among injecting drug users under the
aegis of National AIDS Control Organization (NACO)
since 1990s, including the supply of sterile injecting
equipments and condoms; awareness and education pro-
grams on HIV prevention; clinical services for treating
sexually transmitted infections (STI); referral to the
voluntary counselling and testing Centre (VCTC); and
peer-led outreach programs. A steady decline of HIV
prevalence among IDUs in Manipur, Nagaland and
Mizoram, possibly due to harm reduction efforts has
occurred in recent times. Although declining, Manipur
in 2007 still reported ~18% prevalence of HIV among
the drug injecting population [8]. According to the last
published report of the HIV sentinel surveillance in
India, HIV prevalence in Nagaland, Mizoram, Meghalaya
and Assam among IDUs were 2, 7.5, 4.2 and 2.2%,
respectively [8]. However, recent reports suggest that,
although HIV is declining, nevertheless other blood-
borne pathogens, e.g. HCV, are creating even bigger
problems in this region [9-11]. One recent report in
2009 indicated a 71% prevalence of HCV among IDUs
in Mizoram [11]. Similarly, up to 78% prevalence of
HCV among IDUs was reported from Manipur in 2008
[9]. Despite intervention programs in this region, there
remain longstanding epidemics of HIV and other blood-
borne pathogen problems among IDU populations.
Further assessment is needed to find out the reasons for
this and the spread of these problems to new areas.
Better understanding of the geographical extent of the
drug injecting problem, key characteristics of the IDU
population, their risk behavior, and societal attitude
towards IDUs, is expected to help strengthen HIV pre-
vention interventions in the region. Therefore, the study
was conducted in 5 Northeastern states of India to: 1)
map and assess the characteristics of locations where
t h eI D U sc o u l db ef o u n d ;2 )e x p l o r ea n dd e s c r i b et h e
key characteristics of IDUs and their injection related
risk behaviour, along with and their perception about
attitude of community and healthcare professionals
(HCP) towards them.
Methods
Settings
The study was carried out in 2004. The Northeastern
region of India consists of 7 states that include Aruna-
chal Pradesh, Assam, Nagaland, Manipur, Mizoram, Tri-
pura and Meghalaya. For operational reasons, only 5
states (Assam, Nagaland, Manipur, Mizoram, and
Meghalaya; see Figure 1) were chosen. Three northeast-
ern states (Manipur, Nagaland and Mizoram) share a
common international border with Myanmar and have
close proximity to the infamous golden triangle, the hub
of the heroin trade. Except some parts of Manipur and
Assam, the topography of the region is characterized by
a hilly terrain. Assam is the most populous state of the
region, with 26.6 million people. The population of
other 4 states ranges from 0.9 to 2.4 million at the last
population census in 2001.
Design
Mapping was done to identify the locations where 2 or
more IDUs congregated for injection of drugs or other
purposes (purchasing, injecting and staying). Since 2
IDUs are the minimum requirement for sharing of
injecting equipment, we considered a minimum thresh-
old of two IDUs in defining an IDU location. An IDU
was defined as a person of either sex, aged 18 years or
older, who had injected drugs for non-medical reasons
at least once in the last 6 months. Mapping process was
facilitated by local KIs (Key Informants) who were
knowledgeable about current and previous IDUs. To
assess the characteristics of mapped IDU locations, mul-
tiple qualitative data collection methods were used,
including observation, interviews with KIs and IDUs
from the location. This data helped in cross-checking
the accuracy of collected data and synthesizing the
desired information. We also conducted structured and
semi-structured interviewsw i t hI D U st ou n d e r s t a n d
their injecting practices and other key characteristics.
Separate study teams were formed for each state under
the leadership of a state coordinator (BSA for Manipur,
BL for Nagaland, KSD for Mizoram, CJT for Meghalaya
and BS for Assam) to implement the study in their
respective states. Before the mapping exercise, the study
teams - led by the state coordinators - interviewed KIs
from stakeholders associated with the drug using popu-
lation in each state. The KIs were selected based on
their ability to provide vital information on IDUs for the
state. Initial interviews with KIs from major stakeholders
provided preliminary insight about the geographical
extent of the problem, and the probable locations where
IDUs could be accessed. KIs also helped in selecting the
district and sub-district level personnel who could facili-
tate mapping exercise, help in developing study tools,
and plan our field work. They were included from the
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non-governmental organizations (NGOs)/community-
based organizations (CBOs) working with IDUs (3-9
from each state), drug de-addiction centres (DDC; 2-5
from each state), narcotic/excise departments (2 from
each state), police departments (2-3 from each state),
health departments (2-3 from each state), pharmacies
(2-3 in each state), people living with HIV/AIDS
(PLWH) (1-3 from each state, but none from Meghalaya
and Mizoram) and social welfare department (2 from
each state). Altogether, 118 interviews were conducted
(30 each in Manipur and Nagaland, 20 each in Mizoram
and Meghalaya, and 18 in Assam).
Data Collection
Mapping of the locations were carried out by the field
teams through extensive field visits in all the 5 states, cov-
ering every district and sub-division. People acquainted
with IDUs (e.g. outreach workers and other persons from
NGOs associated with IDU intervention programs, current
and ex-IDUs) acted as KIs to facilitate contact with IDUs.
The snowballing technique (chain of referrals) was
used to identify the locations. The initial KIs were asked
to provide further information about other people able
to provide more information about places of IDUs con-
gregation. This process of identifying KIs continued
until no more new information was forthcoming. Simi-
larly, IDUs in one location were also requested to act as
KIs for further identification of IDU locations. This pro-
cess continued until no new information about IDU
locations was forthcoming. The KIs were requested to
lead the study teams to the locations during peak time
of congregation. Visiting during the peak time helped in
better assessment of the characteristics and activities of
the study population. To ensure quality data, >10% of
locations identified by the field teams were cross-verified
by the state coordinators and other investigators. The
research teams involved in the execution of the study
were trained by social scientists on various methods
and techniques to be adopted for collecting data. After
identifying the locations, the field teams prepared a
hand-drawn sketch of the identified location with its key
landmarks, boundaries and other features. The field
teams spent some time in the locations interacting with
the drug users to build up a rapport with them. The
current/ex-IDUs in the team introduced the field teams
to IDUs in the locations and helped in building trusting
relationship between the field team members and IDUs.
Figure 1 Map of northeastern region of India indicating study states.
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tics of identified locations through direct observations,
interaction with IDUs and the KIs. All the information
during mapping process was collected using a format
developed for this purpose. The data included a geogra-
phical description of the identified location (e.g. state,
district, urban/rural, name of the village/town, important
landmark by which the location could be identified),
types of locations (physical characteristics of locations),
the nature of the location (drug and sex work site,
shooting gallery), demographic information of IDUs (age
and gender), and average numbers of IDUs congregated
in the locations per day. Based on information obtained
during preliminary exploratory interviews with KIs,
types of locations were pre-coded into 8 categories
(such as home, pharmacy, parks, abandoned building,
cemeteries/graveyards, riverside, public toilet, and tea
stalls). However, any new locations found during the
survey were also noted in the format apart from these 8
categories. The average number of IDUs usually
assembled in each location was determined by asking
the KIs or IDUs available in the locations. Similarly,
information about the age ranges of IDUs assembled in
each location was also determined by asking the KIs or
IDUs. A shooting gallery was defined as a place where
injecting equipments were readily available, where it
could be purchased, borrowed or rented. A drug and
sex work site was defined as an IDU location where
IDUs had sex within the group.
Semi-structured qualitative interviews with IDUs were
also conducted to learn about participants’ needle/syr-
inge sharing behaviour and sharing relationships, net-
work size, sources of acquisition of sterile needles and
syringes, and their perception about attitudes of com-
munity and healthcare providers (HCP) towards them.
Additionally, structured closed-ended questions were
also asked to elicit some key information (viz. needle/
syringe sharing behaviour in the past 6 months and net-
work size). IDUs present in the location during the visit
of the study team were recruited purposively for the
interviews. Interviews took ~15 minutes. Only IDUs
aged 18 years or over who had injected drug at least
once in the last 6 months were interviewed. Participants
who were under the influence of drug (intoxicated) and
aggressive were excluded from interviews. Except for
Nagaland (where 2-3 IDU were interviewed), at least
one IDU was interviewed from each selected location.
To assess the network size, aggregate network data [12]
was collected from IDUs by asking “How many IDUs do
you know personally, and in turn who also knew you?”
To assess their needle/syringe sharing practices, IDUs
were asked if they had injected with needle/syringes pre-
viously used by other IDUs, or passed on their used nee-
dle/syringes to others in the last 6 months.
Ethical consideration
The study protocol was reviewed and recommended for
implementation by the Institutional Ethical Committee
of Regional Medical Research Centre (RMRC) of Indian
Council of Medical Research (ICMR). All the interviews
were unlinked and anonymous. No names or any other
personal identifiers of the participants were recorded
anywhere. No information on the target group recruited
was shared with any outside groups. The data regarding
identified locations were not shared with any outside
parties. No interview commenced without prior oral
consent of the respondents. The informed consent form
was either read aloud or thoroughly explained to the
respondents, and once the respondent had provided oral
consent, a member of the teams signed the consent
form on behalf of the respondent.
Data Analysis
The locations of IDUs were categorized according to
various characteristics identified during mapping exer-
cise. All the semi-structured interviews were tape-
recorded and transcribed verbatim. The transcripts were
cross-checked again with the interview tapes. Transcrip-
tions were coded manually to identify important, recur-
rent themes and categories pertaining to the questions
of interest. All the transcripts were read carefully by 2
independent teams to extract the themes and categories.
Initial codes were developed jointly by the investigators
to identify the themes and categories based on detailed
reviews of 4/5 transcripts from each state. However,
codes were further refined as new themes or categories
emerged from the data during the coding process. Any
disagreement between two coding teams was resolved
by discussion. Results of closed-ended-structured ques-
tions (e.g. needle/syringe sharing behaviour in the past
6 months and network size) were expressed as a percen-
tage of the total responses. Analyses were done sepa-
rately for each state.
Results
Mapping of locations
A total of 2462 IDU locations were identified, with the
states sharing a common border with Myamar, i.e.
Manipur, Nagaland and Mizoram, having the highest
number of locations. Manipur had the highest umbers
of sites (1337 locations) followed by Nagaland (475 loca-
tions), Mizoram (294 locations), Meghalaya (186 loca-
tions), and in Assam 170 locations were found. The
number of locations identified per thousand km
2 was
highest in Manipur, followed by Nagaland and Mizoram.
Assam had the lowest numbers of IDU locations per
thousand km
2 (Table 1). The characteristics of IDU
locations assessed during mapping process are described
state-wise follow:
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Of the 1337 IDU locations in Manipur, ~76% were in
rural and 24% in urban areas. Private residences were
the most common gathering places of IDUs (45%)
(Table 2). Other important locations identified were
secluded places such as riversides (8.8%), graveyards
(5.2%), abandoned buildings (2.3%), public parks (3.4%),
public toilets (1.3%), etc. Four IDU locations were also
identified as sex work site. Location-wise average num-
bers of IDUs (average daily congregation in the loca-
tions) are given in Table 3. On average, 6-10 IDUs
assembled in ~48% of the locations daily, followed by
11-20 IDU in ~26% locations. More than 20 IDUs also
assembled in a large number of locations. IDUs were
mostly between early twenties and mid thirties.
Although the majority of locations (51%) were used by
IDUs of different ages (≤25 years and >25 years), 20%
were mostly used by IDUs aged 25 years or less and
~29% by those aged over 25 years. No exclusively female
IDU locations were identified. However, there were
female IDUs in ~10% of the identified locations.
Nagaland
Of the 475 locations identified in Nagaland, 72% were
located in urban areas and 28% in rural areas. Similar to
Manipur, private residences were the most common
gathering places (63.6%) (Table 2). Other locations were
abandoned buildings (11.4%), public toilets (4.4%), tea
stalls (3.2%), pharmacies (2.9%), and river-side (2.1%).
A few locations were also used as shooting galleries in
the state. Six IDU locations were identified as being
used for sex work. An average 6-10 IDUs congregated
in ~39% of the locations daily, whereas ~23% of loca-
tions were used by <6 IDUs (Table 3). IDUs in 33% of
the locations had mostly IDUs of ≤25 years. On the
other hand, ~30% were used by IDUs over 25 years of
age. However, a substantial number of locations (37%)
was used by IDUs of different ages. IDUs were mostly
male (80%). And no exclusively female IDU sites were
identified.
Mizoram
Of a total of 294 IDU locations in Mizoram, the major-
ity (78%) were in urban areas. In contrast to Manipur
and Nagaland, IDUs in Mizoram congregated more in
outdoor/public places than private residences (~17% for
the latter; Table 2). Other places were graveyards
(12.9%), riverside (11.9%), and abandoned buildings
(7.5%). Six shooting galleries were also identified
and another 6 locations were also used for sex work.
About 45% of the locations in Mizoram were used by
6-10 IDUs daily, whereas 33% locations were used by <6
IDUs (Table 3). About 40% of locations were used by
IDUs of different ages (18-35 years) while 30% were
used exclusively by relatively younger IDUs (≤25 years)
and another 30% of locations by aged >25 years. About
82% of locations were exclusively accessed by male
IDUs only, and rest was used by both male and female
IDUs.
Meghalaya
Of a total number of 186 IDU locations identified in
Meghalaya, 81% were in urban areas. About 35% loca-
tions were identified in private residences (Table 2), but
other important locations were various public places,
such as tea-stalls, taxi-stands, liquor shops, market
areas, bus-stops and playgrounds, or isolated places such
as graveyards, forests, river-sides, abandoned-buildings.
Table 1 Distribution of states according to total
populations, land areas, numbers of locations
Sl No States Population
(million)
Land area
(sq km)
Numbers of locations
1 Manipur 2.17 22,327 1337
2 Nagaland 1.99 16,579 475
3 Mizoram 0.89 21,087 294
4 Meghalaya 2.39 22,429 186
5 Assam 26.66 78,438 170
Table 2 State-wise types of locations of IDUs
States
Types of Sites Manipur
n (%)
Nagaland
n (%)
Mizoram
n (%)
Meghalaya
n (%)
Assam
n (%)
Home 602 (45) 302 (63.6) 49 (16.7) 66 (35.5) 18 (10.6)
Riverside 117 (8.8) 10 (2.1) 35 (11.9) 2 (1.1) 8 (4.7)
Parks 45 (3.4) 4 (0.8) 13 (4.4) 4 (2.1) 8 (4.7)
Graveyards 69 (5.2) 3 (0.6) 38 (12.9) 10 (5.3) 7 (4.1)
Pharmacy 3 (0.2) 14 (2.9) 22 (12.9)
Abandoned building 31 (2.3) 54 (11.4) 22 (7.5) 3 (1.6) 4 (2.4)
Public Toilet 17 (1.3) 21 (4.4) 3 (1) 3 (1.6) 14 (8.2)
Tea Stalls 22 (1.6) 15 (3.2) 1 (0.3) 21 (11.2) 14 (8.2)
Others 419 (31.3) 52 (10.9) 133 (45.2) 79 (42.5) 75 (44.1)
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ity of the locations (~55%), 6-10 IDUs used to congre-
gate daily, whereas ~30% were accessed by <6 IDUs
(Table 3). The majority of IDUs were between 18 and
25 years old in all the locations. Some of them were
reported to be <18 years old. About 90% of locations
were exclusively accessed by male IDUs, whereas the
rest were accessed by IDUs of either sex.
Assam
Although Assam was the most populous of the 5 states,
the number of IDU locations identified was the fewest
of all the states. Most of the locations (85%) were situ-
ated in urban areas. Unlike Manipur, Nagaland, Megha-
laya, only a few locations were private residences
(10.6%). Other places, such asp h a r m a c i e s( n=2 2 ) ,t e a
stalls (n = 14), public toilets (n = 14), parks, riverside,
cemeteries, abandoned buildings, auditoriums, saloons,
bazaar area, bus stands, farm houses, forest areas, god-
owns (store-rooms), railway stations, and places used for
religious purposes, could be identified as injecting loca-
tions. Four locations were also found to be used for sex
work. On average, 6-10 IDUs assembled in ~39% of the
locations and about ~32% were frequented by 11-20
IDUs (Table 3). About 18% of the locations were used
by >20 IDUs daily. The IDUs assembled in most of the
locations (69%) were of different ages (18 to 35 years).
In some locations (24%), IDUs <18 years of age were
encountered along with others. About 7% of exclusive
teenager (<18 years) locations were also identified.
About 90% of locations were exclusively used by male
IDUs, with the rest being for either sex.
Interviews with IDUs
Manipur
w?>A total of 1337 male IDUs were interviewed in
Manipur. The aggregate network size of 6-10 was
reported by 39% of IDUs, 11-20 by 33% and >20 by 5%
( F i g u r e2 ) .T h em a j o r i t yo ft h eI D U s( 5 8 % )s a i dt h e y
h a ds h a r e dn e e d l e sa n ds y r i n g e sd u r i n gt h ep a s t6
months (Figure 3), but most of them shared only with
their close friends and regular injecting partners. About
one third of IDUs shared needle and syringes with IDUs
other than their usual injecting partners. Some IDUs
even admitted having shared with strangers. Despite the
presence of NSEPs in all the districts, most of the IDUs
acquired needles and syringes from non-NSEP sources,
such as pharmacies, peddlers and friends on payment.
Many of them reported sharing or re-using needles and
syringes because they were unable to purchase syringes
regularly from pharmacies or peddlers. A major concern
was that they shared or re-used needles and syringes,
often without proper sterilization. This was echoed in
the following statement of an IDU:
“Syringes are available from the drug sellers and
friends only (on payment). So, if we want to inject
we have to re-use the discarded needles and syringes
by washing with plain water. Often we inject from
same needle-syringes in the location.”
About 37% of respondents reported that they mainly
procured sterile needles and syringes from existing pro-
grams (needle syringe exchange programs -NSEP) oper-
ated through drop-in-centres (DIC) or through outreach
workers. But many of them also reported sharing or re-
using needle and syringes on many occasions because of
an interruption in the supply of sterile equipments from
NSEPs. One IDU described the situation:
“I use to take syringes from DIC. I also often share
needles and syringes with my friends because many
times supplies of needles and syringes are stopped.
I often clean needles and syringes with plain water
or bleach before I share with my friends.“
Table 3 State-wise distribution of IDU locations according average numbers of IDUs
States
Numbers of IDUs per locations Manipur
(%) Nagaland
(%) Mizoram
(%) Meghalaya
(%) Assam
(%)
≤5 225 (16.9) 109 (22.9) 81 (32.5) 56 (29.8) 19 (11.2)
6-10 645 (48.3) 183 (38.5) 111 (44.6) 103 (54.7) 67 (39.4)
11-20 349 (26.1) 130 (27.4) 25 (10) 25 (13.3) 54 (31.8)
>20 116 (8.7) 53 (11.2) 32 (12.9) 4 (2.1) 30 (17.6)
Figure 2 Percentage distribution of IDUs according to self-
reported aggregate network size.
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“We get needles and syringes from outreach workers
or from DIC. Sometimes, it is difficult get needles
and syringes from outreach workers or DIC because
of a sudden bandh, a general strike. During this time
we used to clean old used syringes and re-use them
or share syringes among ourselves.”
Similar description was also given by another IDU:
“Our main source of acquiring needles and syringes
is from NGOs. But as this is not available through-
out the year, we start sharing among our friends.
Also, it is not possible to get clean needles and syr-
inges every time we need them, so we are compelled
to share among ourselves.”
Most of the IDUs described HCPs as cordial and non-
discriminatory towards them. However, some IDUs felt
differently. One IDU revealed his experiences with HCPs:
“I was suffering from diarrhea. When I went to a
hospital for treatment, the doctor refused to treat
me, knowing that I am a drug user. Then I went to
a NGO working in the field of HIV/AIDS and took
my treatment there.”
The majority of the IDUs interviewed felt that the atti-
tude of the general community towards them was lar-
gely negative and hostile. Many of them reported
receiving threats or even physical punishments (e.g.
beating) from local underground militant groups for
being drug users. IDUs were highly stigmatized in the
general community. The main reason for stigma
attached to injecting drug use was its association with
HIV/AIDS. An IDU stated:
“Society looks down upon IDUs because they think
that IDUs spread HIV/STIs and other diseases.”
Nagaland
A total of 988 male IDUs were interviewed in Nagaland.
The majority of IDUs (74%) reported smaller network
size (<6). About 23% of IDUs reported their network size
to be 6-10 and a small proportion had 11-20 or >20 IDUs
in their network (Figure 2). Close to 74% of IDUs
reported having shared needles and syringes during past
6 months (Figure 3). Like Manipur, the majority of the
IDUs said that they shared only with their close friends
and with the same injecting partners. However, many
IDUs reported to have shared needles and syringes with
IDUs outside their usual group. Some IDUs also reported
sharing with strangers and new IDUs. The majority of
the IDUs indicated that pharmacies and peddlers were
the only sources of obtaining fresh needles and syringes,
as in Manipur. At the same time, they also reported that
they were unable to purchase fresh needles and syringes
from pharmacies or peddlers for every injection. There-
fore, they most often engaged in syringe sharing with
friends or the re-use of previously used needles and syr-
inges. This situation was described by one IDU:
“I cannot afford to buy needles and syringes every
times whenever I fix; hence I re-use my old needles
and syringes by cleaning them with spirit or plain
water.”
Some desperate users sometimes picked up needles
and syringes from sources such as hospital waste-bins to
meet their needs. This was illustrated by an IDU:
“Many IDUs pick up needles and syringes from the
waste-bins of hospitals, clients, pharmacies and even
veterinary hospitals.”
About 30% of the interviewed IDUs reported that they
usually acquired needles and syringes from available
interventional programs. But, like Manipur, many of
them who acquired needles and syringes from NSEPs
sometimes resorted to risky injecting practices, such as
sharing or re-using syringes because of an interruption
in the supply from NSEPs.
In general, IDUs consistently reported that HCPs were
cordial or friendly towards IDUs. However, some of them
said they faced discrimination from doctors and other
HCPs. According to majority of the participants, the atti-
tude of the community towards IDUs was largely nega-
tive. Most of the IDUs felt that they were discriminated
against, marginalized, looked down upon, and rejected by
the society. On many occasions, IDUs were beaten up
and even locked up for using illicit drugs. One IDU said:
“The community is less concerned about IDUs. We
are hated by the community members and church
Figure 3 Percentage of IDUs who shared needle/syringes in
last six months.
Medhi et al. BMC Public Health 2011, 11:64
http://www.biomedcentral.com/1471-2458/11/64
Page 7 of 11overlooks us. We are isolated from social gatherings
and are considered sinners and criminals”.
Mizoram
A total of 225 IDUs (including one female IDU) were
interviewed. The majority of IDUs (63%) reported a
smaller network size (<6 IDUs) (Figure 2). About 80% of
IDUs reported having shared needles and syringes with
others in the past 6 months (Figure 3). It was common
to share needles and syringes with IDUs who were not
their usual injecting partners. They also reported sharing
with IDUs from other localities; sharing with new injec-
tors and strangers was not uncommon. However, a large
proportion of them also reported sharing only with their
close friends and their regular injecting partners. The
majority of IDUs had to purchase or borrow needles
and syringes from pharmacies, peddlers and friends.
Only a few interviewed IDUs reported that they had
access to free sterile needles and syringes from interven-
tion programs. Therefore, despite being aware of the
adverse consequences, they often engaged in risky
injecting practices, e.g. re-using or sharing of needles
and syringes.
Most of the IDUs said that they were well behaved by
H C P sa n dn o td i s c r i m i n a t e da g a i n s tb e c a u s eo ft h e i r
drug habit. However, a small number of them felt discri-
minated against by HCPs for being IDUs. The commu-
nity at large considered drug use a “bad practice” and a
“social evil”. But, according to most of the IDUs, the
attitude of the community wasm a i n l yp o s i t i v et o w a r d s
them. Some of them said that they were not subjected
to social rejection and isolation, but, many IDUs per-
ceived the community’s attitude towards them as nega-
tive and quite discriminatory.
Meghalaya
A total of 192 IDUs (182 male, 10 female) were inter-
viewed. About 54% reported 6-10 IDUs in their network
(Figure 2), and over a fifth (23%) of them had 11-20
IDUs in their network. Sharing of needles and syringes
appeared to be very high in Meghalaya as >90% of inter-
viewed IDUs admitted having shared needles and syr-
inges in the past 6 months (Figure 3), and most had
shared with other IDUs who were not their usual inject-
ing partners. Some of them also mentioned that they
had sometimes also shared with complete strangers.
However, many of them also said that they shared nee-
dles and syringes only with their regular injecting part-
ners who were usually their close friends. One IDU said:
“I share only with my group members and usually
clean needles and syringes with plain water.”
The overwhelming majority of interviewed IDUs
reported a lack of access to sterile needles and syringes
from NSEPs. They had to purchase or borrow injecting
equipment from pharmacies, friends or peddlers who
contributed in needle syringe sharing and re-use among
IDUs.
The experiences of IDUs with HCPs were mainly posi-
tive. Community at large considered the IDUs as use-
less, a menace and burden to the society. According to
some IDUs, they were often tortured and threatened to
give up the drug habit. Most of the respondents felt that
they were discriminated against, marginalized and stig-
matized by the society. IDUs also tended to hide their
injecting behaviour to avoid negative consequences. One
IDU said-"Nobody knows except my close friends that I
use drugs.”
Assam
In Assam, a total of 111 male IDUs were interviewed.
About a quarter of IDUs (27%) reported a smaller net-
work size (<6 IDUs), while approximately one fifth
(19.1%) of them reported >20 IDUs in their network
(Figure 2). Most of the IDUs (96%) admitted that they
h a ds h a r e dn e e d l e sa n ds y r i n g e si nt h ep a s t6m o n t h s
with other IDUs. Sharing with unknown partners was
reported by many IDUs. Sharing with IDUs from other
places, even from neighboring states (Nagaland and
Manipur) was reported by some IDUs. Like other states,
sharing or re-use of syringes occurred mainly because of
the lack of access to free sterile needles and syringes.
Needles and syringes were mainly purchased from phar-
macies, but some of the IDUs also purchased or bor-
rowed them from drug peddlers and friends.
Most of the IDUs said that they were treated well by
the HCPs. Many IDUs perceived doctors as “supportive”,
“sympathetic” and “friendly” towards them. Most of the
IDUs felt that the attitude of general community was
negative and discriminatoryt o w a r d sI D U s ;t h e yw e r e
considered anti-social and a burden to society.
Discussion
The Northeastern region is experiencing the highest
IDU-related HIV transmission in India and this study
has revealed the extent of the injecting drug use pro-
blem as well as some of the key characteristics of IDUs
in 5 states. In contrast to the popular belief that the
injecting drug use problem was mainly concentrated in
urban areas, this study identified many rural locations of
IDUs. In the worst hit state, Manipur, >70% of sites
were identified in rural and remote areas. Therefore, the
challenge of harm-reduction programs is to reach IDUs
in these locations with difficult geographical terrains
overcoming the socio-environmental barriers [9,13]. As
expected, the study demonstrates that the injecting drug
u s ep r o b l e mw a sm o r ee x t e n s i v ei n3o ft h es t a t e s
(Manipur, Nagaland and Mizoram) bordering Myanmar.
National Aids Control Organization (2006) of India esti-
mated that Manipur was the worst hit state with IDU
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Mizoram had the third highest numbers of IDUs among
northeastern states of India [5].
Majority of the IDU locations were residential homes
in the states of Manipur and Nagaland. Subsequent stu-
dies carried out in these states reconfirmed our findings
[9]. In such settings, identification and providing ser-
vices to IDUs presents a major challenge [9]. Homes
may be safer place for IDUs because of the social unac-
ceptability and clandestine nature of drug use. However,
in Assam and Meghalaya, injecting drug use is still
sporadic and IDUs mostly inject outdoors and in iso-
lated places, such as graveyards. People usually avoid
frequent visits to these places and perhaps for this rea-
son they were chosen for such clandestine activities.
The presence of shooting galleries in some states is of
great concern because these are considered not only
high risk environment for individual users, but may also
act as repositories of contaminating pathogens. Use of
contaminated equipment spread pathogens from an
infected individual to uninfected users [14,15].
Earlier studies showed that younger IDUs who injected
with older subgroups or with those who have injected for
longer duration were at increased risk of blood-borne
infection because of the higher prevalence among the
older subgroups [15-17]. In many sites across the states,
younger and new users were found to be injecting with
older IDUs, making themselves more vulnerable to the
blood-borne infections from older sub-groups. Data
regarding the duration of drug use was not collected in
this study. Nevertheless, findings of a cross-sectional
study involving several districts in this region suggest
that older IDUs usually have longer drug using “careers”
[9]. In Manipur, prevalence of HIV among the IDU
population is ~20% and about three quarter of IDUs is
also infected with HCV [8,9,11]. Hence, in such settings,
new IDUs are certainly at greater risk of contracting
blood-borne infections from older IDUs through sharing
injection equipment. Interventional efforts should there-
fore focus more on young IDUs before they get infected
with blood-borne infectious agents [9].
Injecting drug use is perceived predominantly as a
male problem in India. However, this study highlighted
significant presence of female IDUs in all the 5 north-
eastern states. Further, evidence of sex work in some
locations added a new facet in the transmission
dynamics of HIV infection. Female IDUs may often sell
sex for drugs and for their livelihood in the region [19].
It appears that the dual risks of sexual and drug inject-
ing practices put female IDUs in this region at greater
risk of the acquisition and transmission of HIV infec-
tions. An earlier study in Manipur reported a high pre-
valence of HIV (57%) among female IDUs [18]. Female
IDUs also acting as sex workers in the region may
facilitate transmission of HIV infections to a wider gen-
eral population through their non-IDU sexual partners.
Sizes of injecting networks, and their density and con-
nectivity are key determinants of transmission of blood-
borne infection among IDUs [19-25]. The larger size of
injecting network may have contributed to the rapid
spread of HIV in some parts of Pakistan [20]. Moreover,
a higher level of personal network density and larger
drug network size are positively associated with needle
sharing [25]. During interviews in the present study,
many IDUs disclosed having bigger personal network
(11-20 or more). Many of them also reported sharing
needles and syringes with non-regular injecting partners
and strangers. Recent studies have reconfirmed that the
IDU population in Manipur, Nagaland and Mizoram
have higher levels of shared injecting equipment use
[9,11]. In the present study, many IDUs reported obtain-
ing their needles and syringes from sources other than
government or non-government organization run
NSEPs, which might have contributed to sharing. In the
worst hit states, Manipur and Nagaland, obtaining nee-
dles and syringes from NSEPs was lower despite the
existence of interventional programs. The pharmacy was
an important source of acquiring needles and syringes
among IDUs. However, our findings suggest that the
inability to afford to purchase sterile syringes regularly
forced many IDUs to share or re-use syringes. Also, in a
setting where drug use is not a socially acceptable beha-
v i o u r ,I D U sm a yn o tl i k eo p e n l yt op u r c h a s es y r i n g e s
from pharmacies. Although pharmacies can be added
sources of sterile needles and syringes, and provide ben-
efit in addition to those derived from NSEP [26], cost
and visibility often prevent many IDUs from procuring
needles and syringes from pharmacies in this region.
Continued risky injecting practices among IDUs,
despite the presence of NSEPs, may be attributable to a
number of factors, including environmental barriers.
The socio-political environment in states such as
Manipur and Nagaland affects the consistency of ser-
vices and safety of NGO staffs and IDUs [9,13]. Program
workers may often fail to reach IDUs to distribute sterile
injecting equipments for safe drug injection due to dis-
turbing situations. On many occasions, distribution of
sterile injecting equipment to IDUs is also hampered by
regular police harassment of outreach workers if they
were found with needles and syringes [9,13,27]. Many
IDUs in our study also revealed that the IDUs did not
have any other alternative than re-using old needles and
syringes or sharing them with other IDUs due to the
inconsistencies of interventional programs.
The discriminatory and negative attitude of the com-
munity in general towards IDUs is also a major barrier
in implementing interventions in this region [13].
Therefore, to reduce the negative attitudes of the
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enhancement of community mobilization effort. Envir-
onmental barriers encountered in implementing out-
reach programs can be minimized through mobilizing
the community at large before targeting the IDU popu-
lation [13]. However, more research is needed to under-
stand the causes of continued high-risk injecting
behaviour of IDUs in the region [9,11].
This study has certain limitations that need to be
mentioned. Despite our best efforts, we could not cover
some remote difficult-to-reach areas in the states.
Hence, the problem in the rural and remote areas may
be bigger than we have actually found in this study. Sec-
ondly, many IDUs may not often congregate at identifi-
able and accessible locations because of the clandestine
nature of IDUs’ behaviour. Thus many groups in hard-
to-reach locations remained relatively unexplored.
Therefore, the findings of the assessment may not
reflect the true magnitude of the injecting drug use pro-
blem in different states. However, the findings of this
assessment may indicate adequately the severity of the
problem in different states that is consistent with other
assessments [5]. Thirdly, recruitment of IDUs for the
interview was purposive; hence the findings of the study
m a yb ea f f e c t e db yt h eb i a si n h e r e n ti np u r p o s i v es a m -
pling. Fourthly, except for Meghalaya and Mizoram, no
female IDUs were interviewed in the other 3 states.
Therefore, findings of structured and semi-structured
interviews may not be generalized to all female IDUs.
Conclusions
The study has provided useful information on the inject-
ing drug use problem in the Northeastern region of India
where injecting drug use is the main driver of the HIV
epidemic. The considerable presence of IDUs in the
remote and rural areas of the region with difficult terrain
underscores the need to expand the harm reduction pro-
grams to rural areas. The study has also demonstrated
that risky injecting practices, such as the sharing or re-
use of needles and syringes, is common among IDUs in
all the states. Needles and syringes were mainly procured
from non-NSEP sources by IDUs, which contributed to
the sharing of needles and syringes. Therefore, there is
urgent need to scale up NSEP programs to ensure unin-
terrupted access to sterile injecting equipment to prevent
risky injecting practices among IDUs. Mapping of IDU
sites will be useful in designing strategies for reaching
them. The study also highlighted the largely unexplored
injecting drug use problem of females in this region.
A more innovative strategy will be required to reach this
relatively inaccessible sub-group. Sharing of the same
location by younger and older IDUs, drug and sex inter-
faces are some important findings of the study.
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